Pillar Clinical Research, a Texas-based, multi-specialty clinical research site network, announced on Wednesday that it has named Zach Mitchell as its new chief commercial officer.
In the new role, Mitchell is to head the company's commercial functions and strategy, and continue to execute the company's mission for research to be seen as a care option through community outreach initiatives.
Mitchell has a range of experience in the clinical research industry, spanning operations, business development and project management across multiple therapeutic indications and phases. He has most recently worked as executive director of strategic partnerships for CenExel Clinical Research. He has also served as director of business operations for iResearch Atlanta.
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business
Insmed receives highest ranking in Science's 2024 Top Employers Survey
OncoZenge partners with Pharmanovia for exclusive BupiZenge commercialization in EMENA regions
Viatris added to Forbes' World's Best Employers 2024 list
Rarity Health named finalist for 21st MM+M Rare Disease Agency of the Year